ALPS Advisors’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $670K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $244K | Buy |
|
|||||
|
2023
Q2 | $226K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $195K | Sell |
|
|||||
|
2022
Q2 | $143K | Sell |
|
|||||
|
2022
Q1 | $372K | Sell |
|
|||||
|
2021
Q4 | $374K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $287K | Sell |
|
|||||
|
2020
Q2 | $295K | Sell |
|
|||||
|
2020
Q1 | $248K | Sell |
|
|||||
|
2019
Q4 | $644K | Buy |
|